Open Access Open Access  Restricted Access Subscription Access

An Overview on Polycystic Ovary Syndrome

Mansi R. Patil, Hitendra S. Chaudhari, Dr Sunil P. Pawar, Roshan M. Chaudhari, Rahul B. Lovhare, Yogesh B. Rokde, Mrs Amruta N. Patil

Abstract


PCOS is an endocrine condition that affects females who are of reproductive age. Despite this, the illness is plagued by difficult diagnostic procedures, delayed diagnoses, and inadequate treatment plans. Infertility, insulin resistance, obesity, and cardiovascular disorders are just a few of the health concerns brought on by this syndrome. PCOS is a polygenic, multifactorial, autoimmune, inflammatory, and dysregulated steroid state condition that primarily manifests as a result of poor lifestyle choices. PCOS in the affected females can now be identified thanks to the development of biochemical tests and ultrasound imaging. Therefore, a great deal of knowledge about PCOS has been gained recently. To avoid or treat the negative effects of PCOS, interventions such as oral contraceptives, metformin, and hormone therapy have been developed. However, it appears that altering one's lifestyle to stop abnormal immune activation and reduce exposure to inflammatory substances is the most effective treatment for PCOS. This comprehensive review that includes several hypotheses could make it easier to develop more effective PCOS management strategies.  


Full Text:

PDF

References


Teede, H.J.; Deeks, A.; Moran, L.J. Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010, 8, 41. [CrossRef] [PubMed]

Aversa, A.; La Vignera, S.; Rago, R.; Gambineri, A.; Nappi, R.E.; Calogero, A.E.; Ferlin, A. Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome:

Expert Consensus Resolutions. Front. Endocrinol. 2020, 11, 516. [CrossRef] [PubMed]

Dumesic DA, Abbott DH, Sanchita S, Chazenbalk GD. Endocrine-Metabolic

Dysfunction in Polycystic Ovary Syndrome: an Evolutionary Perspective. Curr Opin Endocr Metab Res 2020;12:41-48. 508

E. Tasali, E. Van Cauter, D.A. Ehrmann, Polycystic ovary syndrome and obstructive sleep apnea, Sleep Med. Clin. 3 (2008) 37–46.

R. Karoli, J. Fatima, A. Chandra, U. Gupta, F. Islam, G. Singh, Prevalence of hepatic steatosis in women with polycystic ovary syndrome, J. Hum. Reprod. Sci. 6 (2013) 9.

S.L. Blay, J.V.A. Aguiar, I.C. Passos, Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis, Neuropsychiatr. Dis. Treat. 12 (2016) 2895–2903.

O. Yang, H.L. Kim, J.-I. Weon, Y.R. Seo, Endocrine-disrupting chemicals: review of toxicological mechanisms using molecular pathway analysis, J. Cancer Prev. 20 (2015) 12–24.

Day F, Karaderi T, Jones MR, et al. Large-scale genome-wide meta-analysis of polycystic ovary 532 syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet 2018; 533 14:e1007813.

Vassalou, H.; Sotiraki, M.; Michala, L. PCOS diagnosis in adolescents: The timeline of a controversy in a systematic review. J. Pediatric Endocrinol. Metab. 2019, 32, 549– 559. [CrossRef]

Apter, D.; Bolton, N.J.; Hammond, G.L.; Vihko, R. Serum sex hormone-binding globulin during puberty in girls and in different types of adolescent menstrual cycles. Acta Endocrinol. (Copenh.) 1984, 107, 413–419. [CrossRef] [PubMed]


Refbacks

  • There are currently no refbacks.